Therefore, we concluded that D2 and NANOG are specifically expressed in the tumor epithelium of BCC and not in the CD34+ population of CSCs and that the expression of D2 and NANOG in CSCs drastically differs from that in the bulk of tumors. Here, NANOG is linked to skin basal cell carcinoma.